203 related articles for article (PubMed ID: 20018915)
1. IL-6 and MYC collaborate in plasma cell tumor formation in mice.
Rutsch S; Neppalli VT; Shin DM; DuBois W; Morse HC; Goldschmidt H; Janz S
Blood; 2010 Mar; 115(9):1746-54. PubMed ID: 20018915
[TBL] [Abstract][Full Text] [Related]
2. IL-6 transgenic mouse model for extraosseous plasmacytoma.
Kovalchuk AL; Kim JS; Park SS; Coleman AE; Ward JM; Morse HC; Kishimoto T; Potter M; Janz S
Proc Natl Acad Sci U S A; 2002 Feb; 99(3):1509-14. PubMed ID: 11805288
[TBL] [Abstract][Full Text] [Related]
3. Plasma cell tumour progression in iMycEmu gene-insertion mice.
Kim JS; Han SS; Park SS; McNeil N; Janz S
J Pathol; 2006 May; 209(1):44-55. PubMed ID: 16482495
[TBL] [Abstract][Full Text] [Related]
4. Insertion of Myc into Igh accelerates peritoneal plasmacytomas in mice.
Park SS; Shaffer AL; Kim JS; duBois W; Potter M; Staudt LM; Janz S
Cancer Res; 2005 Sep; 65(17):7644-52. PubMed ID: 16140930
[TBL] [Abstract][Full Text] [Related]
5. Extraosseous IL-6 transgenic mouse plasmacytoma sometimes lacks Myc-activating chromosomal translocation.
McNeil N; Kim JS; Ried T; Janz S
Genes Chromosomes Cancer; 2005 Jun; 43(2):137-46. PubMed ID: 15751044
[TBL] [Abstract][Full Text] [Related]
6. Novel targeted deregulation of c-Myc cooperates with Bcl-X(L) to cause plasma cell neoplasms in mice.
Cheung WC; Kim JS; Linden M; Peng L; Van Ness B; Polakiewicz RD; Janz S
J Clin Invest; 2004 Jun; 113(12):1763-73. PubMed ID: 15199411
[TBL] [Abstract][Full Text] [Related]
7. Myc translocations in B cell and plasma cell neoplasms.
Janz S
DNA Repair (Amst); 2006 Sep; 5(9-10):1213-24. PubMed ID: 16815105
[TBL] [Abstract][Full Text] [Related]
8. Insertion of c-Myc into Igh induces B-cell and plasma-cell neoplasms in mice.
Park SS; Kim JS; Tessarollo L; Owens JD; Peng L; Han SS; Tae Chung S; Torrey TA; Cheung WC; Polakiewicz RD; McNeil N; Ried T; Mushinski JF; Morse HC; Janz S
Cancer Res; 2005 Feb; 65(4):1306-15. PubMed ID: 15735016
[TBL] [Abstract][Full Text] [Related]
9. Anaplastic, plasmablastic, and plasmacytic plasmacytomas of mice: relationships to human plasma cell neoplasms and late-stage differentiation of normal B cells.
Qi CF; Zhou JX; Lee CH; Naghashfar Z; Xiang S; Kovalchuk AL; Fredrickson TN; Hartley JW; Roopenian DC; Davidson WF; Janz S; Morse HC
Cancer Res; 2007 Mar; 67(6):2439-47. PubMed ID: 17363561
[TBL] [Abstract][Full Text] [Related]
10. Genetic and environmental cofactors of Myc translocations in plasma cell tumor development in mice.
Janz S
J Natl Cancer Inst Monogr; 2008; (39):37-40. PubMed ID: 18648000
[TBL] [Abstract][Full Text] [Related]
11. Abelson murine leukemia virus transforms preneoplastic Emu-myc transgene-carrying cells of the B-lymphocyte lineage into plasmablastic tumors.
Sugiyama H; Silva S; Wang YS; Weber G; Babonits M; Rosén A; Wiener F; Klein G
Int J Cancer; 1990 Nov; 46(5):845-52. PubMed ID: 2228313
[TBL] [Abstract][Full Text] [Related]
12. Lymph nodes and Peyer's patches of IL-6 transgenic BALB/c mice harbor T(12;15) translocated plasma cells that contain illegitimate exchanges between the immunoglobulin heavy-chain mu locus and c-myc.
Kovalchuk AL; Kishimoto T; Janz S
Leukemia; 2000 Jun; 14(6):1127-35. PubMed ID: 10865979
[TBL] [Abstract][Full Text] [Related]
13. A transgenic mouse model of plasma cell malignancy shows phenotypic, cytogenetic, and gene expression heterogeneity similar to human multiple myeloma.
Boylan KL; Gosse MA; Staggs SE; Janz S; Grindle S; Kansas GS; Van Ness BG
Cancer Res; 2007 May; 67(9):4069-78. PubMed ID: 17483317
[TBL] [Abstract][Full Text] [Related]
14. Generation of plasmacytomas with the chromosomal translocation t(12;15) in interleukin 6 transgenic mice.
Suematsu S; Matsusaka T; Matsuda T; Ohno S; Miyazaki J; Yamamura K; Hirano T; Kishimoto T
Proc Natl Acad Sci U S A; 1992 Jan; 89(1):232-5. PubMed ID: 1729694
[TBL] [Abstract][Full Text] [Related]
15. Isotype switch-mediated CH deletions are a recurrent feature of Myc/CH translocations in peritoneal plasmacytomas in mice.
Kovalchuk AL; Janz S
Int J Cancer; 2002 Oct; 101(5):423-6. PubMed ID: 12216069
[TBL] [Abstract][Full Text] [Related]
16. BCL2 accelerates inflammation-induced BALB/c plasmacytomas and promotes novel tumors with coexisting T(12;15) and T(6;15) translocations.
Silva S; Kovalchuk AL; Kim JS; Klein G; Janz S
Cancer Res; 2003 Dec; 63(24):8656-63. PubMed ID: 14695177
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-6 in myeloma/plasmacytoma.
Suematsu S; Matsusaka T; Matsuda T; Hirano T; Kishimoto T
Int Rev Exp Pathol; 1993; 34 Pt A():91-8. PubMed ID: 8454420
[No Abstract] [Full Text] [Related]
18. NF-kappaB/STAT3/PI3K signaling crosstalk in iMyc E mu B lymphoma.
Han SS; Yun H; Son DJ; Tompkins VS; Peng L; Chung ST; Kim JS; Park ES; Janz S
Mol Cancer; 2010 Apr; 9():97. PubMed ID: 20433747
[TBL] [Abstract][Full Text] [Related]
19. ABL-MYC retroviral infection elicits bone marrow plasma cell tumors in Bcl-X(L) transgenic mice.
Linden M; Kirchhof N; Kvitrud M; Van Ness B
Leuk Res; 2005 Apr; 29(4):435-44. PubMed ID: 15725478
[TBL] [Abstract][Full Text] [Related]
20. Murine plasmacytomas, carrier of the t(12;15) chromosomal translocation, develop from immature/mature B cells not from differentiated plasma cells.
Ohno S; Hayakawa J; Hashimoto N; Wiener F
Carcinogenesis; 1999 Apr; 20(4):529-38. PubMed ID: 10223178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
